Comparison 4. Subcutaneous omalizumab versus placebo (without inhaled corticosteroids).
Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
---|---|---|---|---|
1 FEV1 (litres) | 1 | Mean Difference (IV, Fixed, 95% CI) | Totals not selected | |
1.1 Mild asthma | 1 | Mean Difference (IV, Fixed, 95% CI) | 0.0 [0.0, 0.0] | |
1.2 Moderate asthma | 0 | Mean Difference (IV, Fixed, 95% CI) | 0.0 [0.0, 0.0] | |
1.3 Severe asthma | 0 | Mean Difference (IV, Fixed, 95% CI) | 0.0 [0.0, 0.0] | |
2 FEV1 (% predicted) | 1 | Mean Difference (IV, Fixed, 95% CI) | Totals not selected | |
3 Change in PC20 | 1 | Mean Difference (IV, Fixed, 95% CI) | Totals not selected |